FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-17%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.05B
AUM Growth
+$1.05B
(-17%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
48.18%
Holding
82
New
3
Increased
31
Reduced
12
Closed
7
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$19.5M |
| 2 |
Tactile Systems Technology
TCMD
|
$19.1M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$19.1M |
| 4 |
Structure Therapeutics
GPCR
|
$18.9M |
| 5 |
Tandem Diabetes Care
TNDM
|
$17.5M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$146M |
| 2 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$17.4M |
| 3 |
Krystal Biotech
KRYS
|
$11.9M |
| 4 |
Halozyme
HALO
|
$10.3M |
| 5 |
Orthofix Medical
OFIX
|
$7.8M |
Sector Composition
| 1 | Healthcare | 95.63% |
| 2 | Communication Services | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$441M
| $72.1M | 6.85% | 1,494,039 -6,090 | -0.4% | -$294K |
|
2
AtriCure
ATRC
$1.84B
| $65.2M | 6.2% | 1,489,407 +27,772 | +2% | +$1.22M |
|
3
SI-BONE Inc
SIBN
$719M
| $53.6M | 5.09% | 2,524,093 +409,264 | +19% | +$8.69M |
|
|
KRTX
4
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $51.3M | 4.87% | 303,137 +94,391 | +45% | +$16M |
|
|
5
Pliant Therapeutics
PLRX
$101M
| $50.9M | 4.83% | 2,933,260 +1,123,084 | +62% | +$19.5M |
|
6
Crinetics Pharmaceuticals
CRNX
$2.92B
| $47.1M | 4.47% | 1,583,329 +26,107 | +2% | +$776K |
|
|
MODN
7
DELISTED
MODEL N, INC.
MODN
| $46M | 4.37% | 1,886,218 +20,693 | +1% | +$505K |
|
|
BCYC
8
Bicycle Therapeutics
BCYC
$511M
| $41.6M | 3.95% | 2,070,853 +331,404 | +19% | +$6.66M |
|
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $40.1M | 3.81% | 1,125,032 +535,069 | +91% | +$19.1M |
|
10
Alphatec Holdings
ATEC
$2.35B
| $39.3M | 3.74% | 3,033,541 +61,664 | +2% | +$800K |
|
11
NeoGenomics
NEO
$1.13B
| $37.3M | 3.54% | 3,028,913 +336,856 | +13% | +$4.14M |
|
|
FNA
12
DELISTED
Paragon 28, Inc.
FNA
| $34.4M | 3.26% | 2,737,878 +680,571 | +33% | +$8.54M |
|
13
Transmedics
TMDX
$3.92B
| $33.8M | 3.21% | 618,100 +240,636 | +64% | +$13.2M |
|
|
14
Tandem Diabetes Care
TNDM
$845M
| $29.9M | 2.84% | 1,440,966 +840,199 | +140% | +$17.5M |
|
15
Health Catalyst
HCAT
$239M
| $29.7M | 2.82% | 2,930,144 +389,185 | +15% | +$3.94M |
|
|
16
Tactile Systems Technology
TCMD
$297M
| $29.1M | 2.76% | 2,071,419 +1,360,074 | +191% | +$19.1M |
|
|
17
Orthofix Medical
OFIX
$592M
| $23.8M | 2.26% | 1,852,438 -606,691 | -25% | -$7.8M |
|
|
PHLT
18
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $21.2M | 2.01% | 9,378,296 +128,613 | +1% | +$291K |
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $20.6M | 1.95% | 602,070 +263,424 | +78% | +$9M |
|
20
TELA Bio
TELA
$70.5M
| $19.8M | 1.88% | 2,480,264 +754,764 | +44% | +$6.04M |
|
21
OptimizeRx
OPRX
$335M
| $19.3M | 1.84% | 2,486,047 +614,248 | +33% | +$4.78M |
|
|
22
Structure Therapeutics
GPCR
$1.11B
| $18.9M | 1.79% | +374,412 | New | +$18.9M |
|
|
AXNX
23
DELISTED
Axonics, Inc. Common Stock
AXNX
| $18M | 1.71% | 321,173 +8,387 | +3% | +$471K |
|
24
Stevanato
STVN
$6.28B
| $17.4M | 1.65% | 584,755 +470,479 | +412% | +$14M |
|
25
Zentalis Pharmaceuticals
ZNTL
$122M
| $17M | 1.62% | 848,477 +90,642 | +12% | +$1.82M |
|